Focus research 2022 T2i team
Focus research team T2i Using a preclinical orthotopic model of metastatic colorectal cancer, the T2i team demonstrated the systemic anti-metastatic effect of intestinal T lymphocytes capable of migrating to other organs. This finding was then validated in patients...
The power of the intestine against metastases
The power of the intestine against metastases CD8-Positive T-Lymphocytes Neoplasms of the Colon Humans Intégrins Prognosis Virginie Feliu and Dr Christel Devaud Team’s T2i Intestinal α4b7 CD8 T lymphocytes, activated locally in colon tumours, are key effectors...
Towards a new approach to immunotherapy in the treatment of skin cancers
Towards a new approach to immunotherapy in the treatment of skin cancer – the ARC Foundation provides long-term support Over the past 10 years, immunotherapy has significantly improved the management of patients with metastatic melanoma, one of the rarest but...
Christel Devaud awarded by the Amgen France Fund
Talents& awards Award Colorectal cancer is the second most deadly cancer, 25% of patients are diagnosed at an advanced stage with distant metastases and another 25% will eventually develop them. These metastases will settle in the liver in 80% of cases and will be...